CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

BION TEARS

Dextran 70, Hypromellose· ingredient hypromelloseViscoelastic substances· DEXTRAN 70 .1 g/100mL; HYPROMELLOSE, UNSPECIFIED .3 g/100mL; DEXTRAN 70 1 mg/mL; HYPROMELLOSE 2910 (4000 MPA.S) 3 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.29879
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other hypromellose products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Artificial Tears$0.16867−$0.13010
GENTEAL TEARS$0.45293+$0.15410
GenTeal Tears Severe$0.90332+$0.60450
Alcon Tears Lubricant Eye Drops$2.09+$1.79

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.